Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Preventive Approach Against Filgrastim-Induced Bone Pain
NCT06265077Phase 2Completed
- Start
- Feb 2024
- Primary completion
- Oct 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of famotidine, loratadine in bone pain. Started Feb 2024; status: completed.
02
Drugs
famotidineloratadine
03
Conditions
bone pain
Beyond the preview
Go deeper on NCT06265077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06265077.